• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Distinct clinical, laboratory and molecular features of myeloproliferative neoplasm patients with splanchnic vein thrombosis.

作者信息

How Joan, Trinkaus Kathryn M, Oh Stephen T

机构信息

Division of Hematology, Washington University School of Medicine, St. Louis, MO, USA.

Biostatistics Shared Resource, Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO, USA.

出版信息

Br J Haematol. 2018 Oct;183(2):310-313. doi: 10.1111/bjh.14958. Epub 2017 Oct 19.

DOI:10.1111/bjh.14958
PMID:29048104
Abstract
摘要

相似文献

1
Distinct clinical, laboratory and molecular features of myeloproliferative neoplasm patients with splanchnic vein thrombosis.患有内脏静脉血栓形成的骨髓增殖性肿瘤患者的独特临床、实验室和分子特征。
Br J Haematol. 2018 Oct;183(2):310-313. doi: 10.1111/bjh.14958. Epub 2017 Oct 19.
2
Splanchnic venous thrombosis driven by a constitutively activated JAK2 V617F philadelphia-negative myeloproliferative neoplasm: a case report.由持续激活的JAK2 V617F费城阴性骨髓增殖性肿瘤驱动的内脏静脉血栓形成：一例报告
Afr Health Sci. 2014 Dec;14(4):1069-73. doi: 10.4314/ahs.v14i4.39.
3
JAK2V617F prevalence and allele burden in non-splanchnic venous thrombosis in the absence of overt myeloproliferative disorder.无明显骨髓增殖性疾病情况下非内脏静脉血栓形成中JAK2V617F的患病率和等位基因负荷。
Leukemia. 2007 Aug;21(8):1828-9. doi: 10.1038/sj.leu.2404710. Epub 2007 Apr 26.
4
JAK2V617F mutation is ubiquitously present in splanchnic vein thrombosis accompanying myeloproliferative syndromes.JAK2V617F突变普遍存在于伴有骨髓增殖性综合征的内脏静脉血栓形成中。
Aliment Pharmacol Ther. 2011 Jun;33(12):1382-3. doi: 10.1111/j.1365-2036.2011.04670.x.
5
The JAK2 V617F Allele Burden in Latent Myeloproliferative Neoplasms Presenting with Splanchnic Vein Thrombosis.伴有内脏静脉血栓形成的潜伏性骨髓增殖性肿瘤中的JAK2 V617F等位基因负荷
Pathol Oncol Res. 2016 Jan;22(1):229-30. doi: 10.1007/s12253-015-9994-8. Epub 2015 Oct 8.
6
The association of the JAK2 46/1 haplotype with non-splanchnic venous thrombosis.JAK2 46/1 单体型与非内脏静脉血栓形成的关联。
Thromb Res. 2013 Aug;132(2):e86-93. doi: 10.1016/j.thromres.2013.06.021. Epub 2013 Jul 9.
7
JAK2V617F mutation in patients with splanchnic vein thrombosis.JAK2V617F 突变与肠系膜静脉血栓形成。
Dig Dis Sci. 2010 Jun;55(6):1770-7. doi: 10.1007/s10620-009-0933-y. Epub 2009 Aug 19.
8
JAK2 46/1 haplotype predisposes to splanchnic vein thrombosis-associated BCR-ABL negative classic myeloproliferative neoplasms.JAK2 46/1单倍型易患内脏静脉血栓形成相关的BCR-ABL阴性经典骨髓增殖性肿瘤。
Leuk Res. 2012 Jan;36(1):e7-9. doi: 10.1016/j.leukres.2011.08.008. Epub 2011 Sep 3.
9
Calreticulin mutations and their importance in splanchnic vein thrombosis.钙网蛋白突变及其在内脏静脉血栓形成中的重要性。
Br J Haematol. 2016 Jul;174(1):158-60. doi: 10.1111/bjh.13756. Epub 2015 Sep 11.
10
Splanchnic vein thrombosis in patients with myeloproliferative neoplasms: The Mayo clinic experience with 84 consecutive cases.骨髓增殖性肿瘤患者的内脏静脉血栓形成：梅奥诊所连续84例病例的经验
Am J Hematol. 2018 Mar;93(3):E61-E64. doi: 10.1002/ajh.24993. Epub 2017 Dec 18.

引用本文的文献

1
JAK2 mutational status and the contribution of TERT and JAK2 polymorphisms to the occurrence of myeloproliferative neoplasms in Eastern Morocco.摩洛哥东部骨髓增殖性肿瘤中JAK2突变状态以及TERT和JAK2多态性对其发生的影响
Afr Health Sci. 2024 Sep;24(3):138-146. doi: 10.4314/ahs.v24i3.18.
2
Molecular predictors of venous and arterial thrombotic events in patients with myelofibrosis.骨髓纤维化患者静脉和动脉血栓形成事件的分子预测指标
Ann Hematol. 2025 Apr 27. doi: 10.1007/s00277-025-06361-7.
3
Management of Bleeding, Thrombotic and Pregnancy-Related Complications in Women with Myeloproliferative Neoplasms: A Case-Based Review Focusing on Sex-Specific Challenges.
骨髓增殖性肿瘤女性患者出血、血栓形成及妊娠相关并发症的管理：基于病例的综述，聚焦性别特异性挑战。
J Clin Med. 2025 Feb 25;14(5):1537. doi: 10.3390/jcm14051537.
4
Abdominal venous thromboses: detection of the p.V617F mutation by next-generation ultradeep sequencing-A prevalence study of patients in Mecklenburg-West Pomerania (2017-2021).腹部静脉血栓形成：通过新一代超深度测序检测p.V617F突变——梅克伦堡-前波美拉尼亚患者的患病率研究（2017 - 2021年）
Front Med (Lausanne). 2024 Jan 11;10:1344769. doi: 10.3389/fmed.2023.1344769. eCollection 2023.
5
Splanchnic Vein Thrombosis in Myelofibrosis-An Underappreciated Hallmark of Disease Phenotype.骨髓纤维化中的内脏静脉血栓形成——疾病表型的一个被低估的特征。
Int J Mol Sci. 2023 Oct 29;24(21):15717. doi: 10.3390/ijms242115717.
6
A Comparison of Bone Marrow Morphology and Peripheral Blood Findings in Low and High Level V617F Allele Burden.低水平和高水平V617F等位基因负荷下骨髓形态学与外周血检查结果的比较
Diagnostics (Basel). 2023 Jun 16;13(12):2086. doi: 10.3390/diagnostics13122086.
7
Shedding Light on the Pathogenesis of Splanchnic Vein Thrombosis.揭示内脏静脉血栓形成的发病机制。
Int J Mol Sci. 2023 Jan 23;24(3):2262. doi: 10.3390/ijms24032262.
8
Diagnostic and Therapeutic Challenges of Chronic Portal Vein Thrombosis Secondary to Myeloproliferative Neoplasm in Sub-Saharan Region: A Series of Cases and Literature Review.撒哈拉以南地区骨髓增殖性肿瘤继发慢性门静脉血栓形成的诊断和治疗挑战：一系列病例及文献综述
Int Med Case Rep J. 2023 Jan 5;16:13-25. doi: 10.2147/IMCRJ.S385219. eCollection 2023.
9
JAK2V617F variant allele frequency >50% identifies patients with polycythemia vera at high risk for venous thrombosis.JAK2V617F 等位基因变异频率>50%可识别出患有静脉血栓形成高风险的真性红细胞增多症患者。
Blood Cancer J. 2021 Dec 11;11(12):199. doi: 10.1038/s41408-021-00581-6.
10
Polycythemia vera: historical oversights, diagnostic details, and therapeutic views.真性红细胞增多症：历史的忽视、诊断的细节和治疗的观点。
Leukemia. 2021 Dec;35(12):3339-3351. doi: 10.1038/s41375-021-01401-3. Epub 2021 Sep 3.